Gribkoff VK, Winquist RJ. Potassium channelopathies associated with epilepsy-related syndromes and directions for therapeutic intervention. Biochem Pharmacol 2023;208:115413. [PMID: 36646291 DOI: 10.1016/j.bcp.2023.115413][Reference Citation Analysis]
2
Qunies AM, Mishra NM, Spitznagel BD, Du Y, Acuña VS, David Weaver C, Emmitte KA. Structure-activity relationship studies in a new series of 2-amino-N-phenylacetamide inhibitors of Slack potassium channels. Bioorganic & Medicinal Chemistry Letters 2022. [DOI: 10.1016/j.bmcl.2022.129013][Reference Citation Analysis]